SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950123-00-001087
Filing Date
2000-02-11
Accepted
2000-02-11 00:00:00
Documents
1
Group Members
JOHNSON & JOHNSONJOHNSON & JOHNSON DEVELOPMENT CORP

Document Format Files

Seq Description Document Type Size
1 AMYLIN PHARMACEUTICALS, INC. SC 13D/A 15910
  Complete submission text file 0000950123-00-001087.txt   17848
Mailing Address
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 9085240400
JOHNSON & JOHNSON (Filed by) CIK: 0000200406 (see all company filings)

IRS No.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0103
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9373 TOWNE CENTRE DR SAN DIEGO CA 92121
Business Address 9373 TOWNE CENTRE DR SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Subject) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-42168 | Film No.: 534570
SIC: 2834 Pharmaceutical Preparations